TGTX Stock Outperforms 95% of Stocks. Here's Why.

Biotech stock TG Therapeutics is building a cup base after a sell-off in early August. It is testing a key moving average. The post TGTX Stock Outperforms 95% of Stocks. Here's Why. appeared first on Investor's Business Daily.